Oxford Sciences Innovation has led a $13.4m series A round for Ultromics, an Oxford spinout working on technology to diagnose coronary heart disease.

Ultromics, a UK-based artificial intelligence (AI) technology developer focused on coronary heart disease, raised £10m ($13.4m) in series A funding yesterday led by university venture fund Oxford Sciences Innovation.

Neptune, RT Ventures, GT Healthcare, Tanarra and Fushia also participated in the round, as did private investors Andre Crawford-Brunt and Dieter Spälti.

Founded in May 2017, Ultromics has created echocardiography analysis technology called Topological Analysis. An echocardiogram is a form of ultrasound scan that is used to check the structure of…